Abstract:OBJECTIVE:To study the effects of serum IgA(1) from patients with IgA nephropathy (IgAN) on the phosphorylation of extracellular signal-regulated kinase (ERK) and proliferation of human mesangial cells (HMC).METHODS:Serum was taken from 10 IgAN patients and 10 healthy persons. IgA(1) was isolated with jacalin column, and then heated to become aggregated form (aIgA(1)). Primary HMCs were cultured and the cells of third or fourth generation were used in the test. HMCs were incubated with aIgA(1) from IgAN patients or from healthy persons. To do blocking test 50 micro mol/L PD98059 was added into the culture of HMC of the 3 groups while the HMCs were in the relatively stationary phase. The phosphorylation of ERK was evaluated by Western blot; cell cycle was examined by DNA fluorescence labeling and flow cytometry. HMC number was counted.RESULTS:1) Both the aIgA(1) from patients with IgAN and that from healthy persons induced the phosphorylation of ERK, DNA synthesis and proliferation of HMC in a time-dependent manner and with a similar trend, however, the effects of aIgA(1) from patients with IgAN were much stronger and longer. The incubation times for the maximum effect on phosphorylation of ERK were 15 minutes, 24 - 36 hours, and 48 - 72 hours in the IgAN patient group, healthy person group, and the control group with a ratio of phosphorylated ERK/total ERK of 49.5% +/- 10.1%, 30.7% +/- 4.4% and 10.5% - 12% respectively (P < 0.05). 2) After 18-hour incubation, the percentages of cells at the stage S were 3.48% +/- 0.54%, 6.64% +/- 0.96%, and 7.85% +/- 0.71% in the control group, healthy person group, and IgAN patient group. 24 hours after incubation, the percentages of cells at stage S-G(2)-M were 9.4% +/- 1.86% in the control group, significantly lower than that in the healthy person group (14.5% +/- 0.7%, P < 0.05) and that of the patient group (17.2% +/- 0.3%, significantly higher than the other 2 groups, P < 0.01 and P < 0.05). At the peak time, the cells at stage S-G(2)-M accounted for 33.0% +/- 0.3% and 30.7% +/- 0.7% in the patient group and healthy person group respectively (P < 0.05) with the HMC count of (57.8 +/- 2.5) x 10(4)/ml and (50 +/- 1.5) x 10(4)/ml (P < 0.05) respectively. After 48, 72, and 96-hour incubation with aIgA(1) the HMC counts were (51.7 +/- 1.6) x 10(4)/ml, and (56.4 +/- 2.6) x 10(4)/ml, and (58.8 +/- 1.8) x 10(4)/ml, and (65.8 +/- 2.9) x 10(4)/ml, (60.0 +/- 1.7) x 10(4)/ml and (66.8 +/- 2.0) x 10(4)/ml in the patient group with and without pre-incubation of PD98059 respectively (P < 0.05). However, the HMC count was not significantly changed in the healthy person group. Blocking of ERK with PD98059 could inhibit the effect of aIgA(1) from patients with IgAN on the proliferation of HMC but could not inhibit the effects of aIgA(1) from healthy controls.CONCLUSION:IgA(1) induces the phosphorylation of ERK, DNA synthesis and proliferation of HMC, and the effects of IgA(1) from patients with IgAN are stronger than that from healthy persons.

The feasibility of EBV-immortalized B cells for study of IgA nephropathy

Plasma EBV miRNAs Profiles Reveal Potential Biomarkers for clinical prognosis of Acquired Immune Deficiency Syndrome-related Lymphoma

Plasma EBV miRNA Profiles Reveal Potential Biomarkers for Clinical Prognosis of Acquired Immunodeficiency Syndrome-related Lymphoma

Progress in Pathogenesis of Immunoglobin A Nephropathy

Increased April Expression Induces Iga1 Aberrant Glycosylation In Iga Nephropathy

The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies

The transcription factor HMGB2 indirectly regulates APRIL expression and Gd-IgA1 production in patients with IgA nephropathy

The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy

IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy

Proteins induced by telomere dysfunction are associated with human IgA nephropathy.

B cell targeting in IgA nephropathy

Integrated analysis of B‑cell and T‑cell receptors by high‑throughput sequencing reveals conserved repertoires in IgA nephropathy

Expression profile of BAFF in peripheral blood from patients of IgA nephropathy: Correlation with clinical features and Streptococcus pyogenes infection

Retrospective Analysis of EB Virus Infection in Patients with Angioimmunoblastic T-cell Lymphoma and Its Clinical Significance

The Landscape and Diagnostic Potential of T and B Cell Repertoire in Immunoglobulin A Nephropathy

[Serum IgA(1) from Patients with IgA Nephropathy Induces Phosphorylation of Extracellular Signal-Regulated Kinase and Proliferation of Human Mesangial Cells].

Causal association between peripheral immune cells and IgA nephropathy: a Mendelian randomization study

IgA1 from Patients with IgA Nephropathy Induced Release of Calcium,up-Regulation of TGF-β Mrna Expression and Secretion of Fibronectin in Human Glomerular Mesangial Cells

Genetic Abnormalities Assist in Pathological Diagnosis and EBV-positive Cell Density Impact Survival in Chinese Angioimmunoblastic T-cell Lymphoma Patients